Gapping down
In reaction to disappointing earnings/guidance: CAMP -15.3%
Select oil/gas related names showing early weakness:
In reaction to disappointing earnings/guidance: CAMP -15.3%
Select oil/gas related names showing early weakness:
- SDRL -4.8%, SDPI -4.7%, TOT -1.7%, WLL -1.2%, COP -1%, RIG -0.8%, BT -0.7%, PBR -0.6%
Other news:
- THLD -61.8% ( to discontinue investment in its Tarloxotinib Program after interim data; implementing workforce reduction)
- MIRN -17.1% (Mirna Therapeutics Investigational New Drug for MRX34 has been placed on full clinical hold)
- DCTH -13% ( intends to offer shares of its common stock and warrants to purchase shares of common stock in an underwritten public offering)
- ABUS -10.8% (reports interim results from the first two cohorts of the ongoing ARB-1467 Phase II multi-dose clinical trial in chronically infected HBV patients)
- VNRX -8.5% ( announces proposed public offering of common stock)
- CNO -3.9% (terminating reinsurance agreements with Beechwood Reand; will suspend its share repurchase program for the rest of 2016)
- STAY -3.6% (prices secondary offering and repurchase of paired shares; paired shares sold at $14.25 per share)
- ABR -2.9% (to offer $75 mln convertible senior notes due 2019 in an underwritten public offering)
- IRT -2.6% (prices public offering of 25 mln shares of common stock at $9.00 per share for total gross proceeds of $225.0 mln)
- SNE -2.2% (Nikkei down 1.5% overnight)
Analyst comments: CORE -0.9% (downgraded to Hold at Jefferies)